Biomarker: F347-IgE Quinoa

Overview

Quinoa is the edible seed of Chenopodium quinoa, a pseudocereal in the Amaranthaceae family. It is primarily encountered as a food, including whole seeds, flour, pasta, and prepared dishes, and occupational exposure to airborne quinoa flour has also been reported. IgE-mediated reactions to quinoa appear to be uncommon but may include urticaria, angioedema, respiratory symptoms, gastrointestinal symptoms, and anaphylaxis. Evaluation of quinoa-specific IgE in serum may help assess suspected sensitization when symptoms occur after ingestion or occupational exposure, but a positive result indicates sensitization and does not by itself establish clinical allergy.

Clinical Use Cases

Evaluation of suspected IgE-mediated food allergy: Serum quinoa-specific IgE may be considered when a compatible history of symptoms follows quinoa ingestion.
Investigation of exposure-related symptoms: Testing may support evaluation of urticaria, angioedema, wheezing, gastrointestinal symptoms, or anaphylaxis occurring after quinoa-containing foods.
Assessment of occupational allergy: Quinoa-specific evaluation may be relevant in individuals who develop respiratory symptoms while handling quinoa seed or flour.
Clinical correlation: Results should be interpreted with the exposure history, timing and reproducibility of symptoms, physical findings, and other allergy testing.
Confirmation of clinical reactivity: When the diagnosis remains uncertain, an allergist-supervised oral food challenge may be considered because serum-specific IgE demonstrates sensitization rather than definite clinical reactivity.
Evaluation of possible coexisting sensitization: Testing for other foods or inhalant allergens may be considered when the clinical history suggests alternative explanations or potential cross-sensitization.

Specimen Types

Serum: Commonly used for measurement of quinoa-specific IgE in a blood sample.
Plasma: May be accepted by some validated laboratory platforms, depending on the laboratory method.

Measurement Methods

Allergen-specific IgE testing: Measures IgE antibodies in serum or blood directed against quinoa proteins. The result supports assessment of sensitization but does not independently confirm food allergy.
Immunoassay-based testing: Clinical specific-IgE assays generally use an immunoassay format to detect and quantify allergen-specific IgE.
Component-resolved diagnostics: No clinically established quinoa-specific molecular component testing was identified. Published clinical reports have described IgE-binding quinoa proteins, but these findings have not established a routinely validated component panel for clinical diagnosis.
Skin testing: Skin-prick or prick-to-prick testing with quinoa material has been reported in clinical cases, but results assess sensitization and require interpretation with the clinical history.
Supervised oral food challenge: May provide the most direct assessment of clinical reactivity when the diagnosis cannot be established from history and IgE testing alone.

Test Preparation and Influencing Factors

Preparation: Routine fasting is generally not required for an allergy blood test.
Medications: Patients should report antihistamines and other medicines to the clinician. Medication changes should be made only according to clinical instructions.
Timing of collection: A serum-specific IgE result should be interpreted in relation to the timing of the suspected reaction and the patient’s subsequent exposure history. A delayed sample does not by itself establish or exclude clinical allergy.
Total IgE concentration: Very high total IgE may be associated with multiple positive specific-IgE results of uncertain clinical relevance. Specific-IgE concentrations should therefore be interpreted in context.
Age and clinical history: The meaning of a result depends on age, dietary exposure, symptoms, and the prior probability of quinoa allergy. Reference thresholds do not replace clinical assessment.
Sensitization versus allergy: Detectable quinoa-specific IgE indicates immunologic sensitization. It does not prove that quinoa ingestion or inhalation will cause symptoms.
Test concentration: Higher specific-IgE concentrations may increase the likelihood of clinical reactivity for some foods, but the result does not reliably predict reaction severity and quinoa-specific predictive thresholds are not well established.
Cross-reactive sensitization: A positive result may reflect recognition of proteins shared with related plant sources or other foods. This possibility should be considered when the exposure history is not consistent with symptoms.
Assay variation: Results from different platforms may not be directly interchangeable. Interpretation should use the reporting units and reference intervals provided by the performing laboratory.

Cross-Reactivity

Related plant sources: Human clinical evidence for clinically meaningful quinoa cross-reactivity is limited. A 2019 occupational case report described suspected cross-reactivity between quinoa and amaranth flour, but the authors presented this as a hypothesis rather than a broadly established clinical pattern.
Other grains and seeds: Published clinical and laboratory observations have reported IgE recognition involving quinoa and buckwheat, wheat, or rice extracts, but such immunologic findings do not establish that patients will clinically react to all of these foods.
Protein families: Quinoa seed proteins, including storage-protein families such as 11S-type globulins, have been reported as IgE-binding proteins in case-based investigations. A routinely validated quinoa component panel has not been established.
Pollen sensitization: Quinoa belongs to the same broad botanical family as some pollen-producing plants, but clinically meaningful cross-allergy between quinoa seed and related pollens has not been sufficiently established for routine interpretation.
Clinical relevance: Cross-reactive IgE binding can produce a positive test without symptomatic cross-allergy. Sensitization to quinoa or a related source should therefore be assessed separately from documented reactions after exposure.

Synonyms

Common name: Quinoa
Scientific name:Chenopodium quinoa
Food forms: Quinoa seed, quinoa flour, quinoa pasta, and quinoa grain substitute
Allergen designation: F347